Communiqués

26/01/23 CeCors Finalizes Terms with VetComm to Enter the Multi-Billion Dollar Veteran Benefits Industry AQ
19/12/22 CeCors, Inc. Announces Binding Letter of Intent to Acquire VetComm Corp. AQ
06/12/22 PsyKey Inc. Adds Mental Health Support Advocate Dr. Shahiem Hartley to its Medical Advisory Board AQ
16/11/22 PsyKey, Inc. Announces Renowned Biochemist Dr. Michael J. McCarthy as Member of Scientific & Medical Advisory Board GL
31/10/22 PsyKey, Inc. Announces Veteran Corporate Executive & Scientific Innovator John Gustin as Head of Global Business Development EQ
31/10/22 PsyKey, Inc. Announces Veteran Corporate Executive & Scientific Innovator John Gustin as Head of Global Business Development AQ
15/08/22 CECORS : PsyKey Inc. Prepares to Enter $23 Billion Global Box Subscription Market With its Functional Mushroom Products PU
28/07/22 CeCors : Issues Statement Regarding Unauthorized Stock Promotion PU
14/04/21 PsyKey Inc. Announces Letter of Intent with MycoVita Canada to Form Strategic Partnership for Advanced Mycology Product Development NE
29/03/21 PsyKey Inc. Announces Former Royal Bank of Canada Managing Director to Head Advisory Board NE
14/01/21 Cecors, Inc. Shareholder Update NE
12/08/19 CeCors, Inc. Announces New Value-Added Feature to RASCI’s Menu of Services for Healthcare Providers GL
07/08/19 CeCors, Inc. Establishes an Inside Sales Channel for Its Medical Records & Data Business GL
05/08/19 CeCors, Inc. to Acquire 100% of Medical Records and Data Company GL
10/06/19 CeCors Inc. Preparing Final Stages of Launching CannMedLive App GL
Aucun résultat pour cette recherche